Home
    Preliminary Topics
    Registration
    Accommodation
    Contact
Home
Welcome Note
Committees
Local Advisory Board
Faculty
Timetable
Scientific Program
Poster Presentations
Poster Presentation Guidelines
CME
Sponsorship & Exhibition
Sponsors
Exhibitors
Registration
Accommodation
Hotel Rey Juan Carlos
Hotel Husa Illa
Hotel Senator Barcelona
General Information
Before you travel...
Invitation Letter
About Barcelona
Partners
Links
COPHy 2010
COPHy 2010 Sponsors
The 2nd World Congress on
Controversies in Ophthalmology (COPHy)

Catalonia Palace of Congresses, Barcelona, Spain, March 3-6, 2011
  Scientific Program Print
Friday, March 4, 2011
        
Hall A  
  
Session 1
08:30-10:00
 
Oculoplastics: Controversies in Oculoplastics, LacrimaI and Orbits I
Chairpersons: G. Rose, UK & R. Medel, Spain
Capsule:
Diagnosis and treatment of lacrimal system abnormalities are still under debate
  
  
Welcome: G. Rose, UK
  
08:30-09:00
  
08:30-08:40
  
08:40-08:50
  
08:50-09:00
Debate: Dacryocystography has almost no role in the routine assessment of lacrimal drainage problems
Pro
D. Verity, UK
Con
J. Prat Bartomeu, Spain
Discussion
   
09:00-09:30
 
09:00-09:10
 
09:10-09:20
 
09:20-09:30
Debate: Integrated (porous) orbital implants have no measurable advantage in socket surgery
Pro 
G. Rose, UK
Con
R. Guthoff, Germany
Discussion
      
09:30-10:00
Short Debates
1) Implants should be placed at the time of primary evisceration for infective endophthalmitis
2) Endoscopic brow-lifts are of doubtful value and have poor long-term outcome
3) There is no role of biocorporal flaps in the surgery for soley orbital disease
4) Artificial eyes should be removed daily for cleaning, rather than being left for long periods without attention
Moderator:
N. Rosen, Israel
Panel:
M. Gonzalez-Candial, Spain
R. Guthoff, Germany
R. Hermida, Spain
R. Medel, Spain
G. Rose, UK
J. Prat-Bartomeu, Spain
W. van den Bosch, The Netherlands
D. Verity, UK
     
10:00-10:30 Coffee Break
   
10:30-12:00
(Hall A)
 
 
Chairpersons:
   
10:30-10:45
  
  
10:45-11:00
 
  
11:00-11:15
 
  
11:15-11:30
 
 
11:30-11:45
 
  
11:45-12:00
 
Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology
 
A. Loewenstein, Israel & S. Lightman, UK
  
Lecture: More to ME than meets the eye
J. Ambati, USA
 
Lecture: SCORE
N. Bressler, USA
 
Lecture: BRAVO
A. Augustin, Germany
 
Lecture: GENEVA
F. Bandello, Italy
 
Lecture: Analyzing apples to apples in clinical trials - introducing the rationale for COMO
A. Loewenstein, Israel
 
Lecture: Perspectives of steroids in the management of ME
S. Lightman, UK
  
12:00-13:00 Lunch Break
   
Session 2
13:00-14:30
Glaucoma I
Chairpersons: A. Heijl, Sweden & H.D. Jampel, USA
Capsule:
Preferred glaucoma screening methods
 
13:00-13:30
13:00-13:10
 
13:10-13:20
  
13:20-13:30
Debate: Selective perimetry is often useful
Yes
D. Friedman, USA
No
A. Heijl, Sweden
Discussion
 
13:30-14:00
13:30-13:40
  
13:40-13:50
   
13:50-14:00
Debate: Screening for glaucoma
Justified
D. Friedman, USA
Not justified
H.D. Jampel, USA
Discussion
  
14:00-14:30
14:00-14:10
 
14:10-14:20
  
14:20-14:30
Debate: IOP fluctuation
Important
H.D. Jampel, USA
Not important
A. Heijl, Sweden
Discussion
 
14:30-15:00 Coffee Break
    
Session 3
15:00-16:30
Glaucoma II
Chairpersons: D. Friedman, USA & A. Heijl, Sweden
Capsule:
Various treatment modalities in glaucoma - still under debate
  
15:00-15:30
15:00-15:10
 
15:10-15:20
  
15:20-15:30
Debate: Preperimetric glaucoma
Treat
L. Rossetti, Italy
Don't treat
G. Sunaric Megevand, Switzerland
Discussion
 
15:30-16:00
16:00-16:10
  
16:10-16:20
   
16:20-16:30
Debate: First-line treatments in open-angle glaucoma 
Trabeculectomy – surgical intervention
H.D. Jampel, USA
SLT
S. Melamed, Israel
Other
P. Foster, UK
   
16:00-16:30
16:00-16:10
  
16:10-16:20
  
16:20-16:30
Debate: Treatment of closed angle glaucoma
Iridotomy
D. Friedman, USA
Cataract extraction
P. Foster, UK
Discussion
 
Session 4
16:30-18:00
Oculoplastics: Controversies in Oculoplastics, LacrimaI and Orbits II
Chairpersons: G. Rose, UK & D. Verity, UK
Capsule:
Debates related to orbital disease
 
 
Welcome: G. Rose, UK & D. Verity, UK
  
16:30-17:00
  
16:30-16:40
 
16:40-16:50
  
16:50-17:00
Debate: Oral antibiotics are now the primary treatment of choice for infective orbital cellulitis
Yes
W. ven den Bosch, The Netherlands
No
M. Gonzalez-Candial, Spain
Discussion
   
17:00-17:30
 
17:00-17:10
 
17:10-17:20
 
17:20-17:30
Debate: Pleomorphic adenomas should be biopsied as they can be removed without complication
Yes
N. Rosen, Israel
No
R. Hermida, Spain
Discussion
    
17:30-18:00
Short Debates
1) Lacrimal sac abcesses should be drained and DCR deferred until inflammation settles
2) Orbital wall fractures should generally have early repair
3) Silicone rods are the preferred brow suspension material for patients with severe myopathic ptosis
4) Anti-metabolites should routinely be used during revisional lacrimal drainage surgery
5) DCR is a nasal operation and should be performed by ENT surgeons!
Moderator:
R. Medel, Spaihn
Panel:
M. Gonzalez-Candial, Spain
R. Guthoff, Germany
R. Hermida, Spain
J. Prat-Bartomeu, Spain
G. Rose, UK
N. Rosen, Israel
W. van den Bosch, The Netherlands
D. Verity, UK
 
Hall B  
 
Session 5
08:30-10:00
  
Pediatrics I: Strabismus
Chairpersons: P. Nucci, Italy & K.K. Nischal, UK
Capsule:
Questionable strabismus treatment modalities
  
08:30-09:15
Panel Discussion: Accommodative Estropia
Panel:
D. Granet, USA
R. Gomez de Liano, Spain
D. Mojon, Swizterland
       
09:15-10:00
Panel Discussion: Brown Syndrome and Duane Syndrome
Panel:
D. Granet, USA
R. Gomez de Liano, Spain
D. Mojon, Swizterland
    
10:00-10:30 Coffee Break
   
10:30-12:00
(Hall A)
Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology
     
12:00-13:00 Lunch Break
     
Session 6
13:00-14:30
Trauma I
Chairpersons: F. Kuhn, USA & J. Moisseiev, Israel
Capsule:
Ocular trauma treatment
  
13:00-13:45
13:00-13:10
 
13:10-13:20
 
 
13:20-13:30
  
13:30-13:45
Update Lectures
Traumatic optic neuropathy: Management, neuroprotection, regeneration
N. Miller, USA
Shaken baby syndrome: Ocular and associated systemic findings, medical and surgical management, amblyopia prevention
W. Schrader, Germany
Surgical options for reconstruction after traumatic cataract repair
D. Sachs, Israel
Discussion with panel:
F. Kuhn, USA
N. Miller, USA
J. Moisseiev, Israel
N. Rosen, Israel
D. Sachs, Israel
W. Schrader, Germany
     
13:45-14:30
13:45-14:00
 
14:00-14:15
  
14:15-14:30
Debate: Enucleation and evisceration in the management of severe eye injury
Pro: Removal of the globe is essential
N. Rosen, Israel
Con: The globe should be preserved
F. Kuhn, USA
Discussion with panel:
F. Kuhn, USA
N. Miller, USA
J. Moisseiev, Israel
N. Rosen, Israel
D. Sachs, Israel
W. Schrader, Germany
   
14:30-15:00 Coffee Break
      
Session 7
15:00-16:30
Trauma II
Chairpersons: J. Moisseiev, Israel & F. Kuhn, USA
Capsule:
Specific situations in ocular trauma
  
15:00-15:45
15:00-15:15
  
15:15-15:30
  
15:30-15:45
Update Lectures
Traumatic macular hole
J. Moisseiev, Israel
Combined anterior and posterior trauma
P. Sternberg, USA
Discussion
  
15:45-16:30
Case Presentation and Panel Discussion: Anterior and posterior segment
Moderators:
J. Moisseiev, Israel & F. Kuhn, USA
Panel:
A. Barak, Israel
W. Mieler, USA
W. Schrader, Germany
P. Sternberg, USA
    
Hall C   
 
Session 8
08:30-10:00
 
Cataract: Complicated Situations in Cataract Sugery I
Chairpersons: W.J. Stark, USA & E. Assia, Israel
Capsule:
Cataract surgery: Problems still to be solved
  
08:30-09:00
08:30-08:40
  
08:40-08:50
  
08:50-09:00
Debate: IFIS: Surgical thrill or no big deal?
No more than some minor modifications
R. Barraquer, Spain
Hooks, OVDs and low settings
Z. Biro, Hungary
Discussion
 
09:00-09:30
09:00-09:10
  
09:10-09:20
  
09:20-09:30
Debate: Astigmatism correction should be performed during lens surgery or not?
Toric IOL
J. Alio, Spain
Yes, there are
G. Kymionis, Greece
Discussion
  
09:30-09:45
 
  
09:45-10:00
Lecture: Cataract surgery: Does it increase AMD progression or not?
W.J. Stark, USA
  
Lecture: Femtosecond laser cataract surgery
J. AlioSpain
        
10:00-10:30 Coffee Break
     
10:30-12:00
(Hall A)
Retina Symposium
Never Judge a Book by its Cover
Sponsored by Allergan Ophthalmology
    
12:00-13:00 Lunch Break
    
Session 9
13:00-14:30
Medical Retina I
Chairpersons: G. Coscas, France & F. Bandello, Italy
Capsule:
AMD - Lucentis? Avastin? VEGF trap? Others?
    
13:00-13:30
13:00-13:10
  
13:10-13:20
  
13:20-13:30
 
Debate: The role of adjunctive treatment in AMD treatment
Adjunctive therapy is not needed
E. Souied, France
Adjunctive therapy (e.g. PDT, brachytherapy) - maybe helpful
A. Augustin, Germany
Radiation adjunctive therapy may be helpful
P. Dugel, USA
Panel Discussion
Moderator:
U. Chakravarthy, UK
Panel:
E. Basauri, Spain
G. Coscas, France
P. Dugel, USA
A. Loewenstein, Israel
G. Soubrane, France
         
13:30-14:00
13:30-13:38
  
13:38-13:46
  
13:46-13:53
 
13:53-14:00
Debate: Avastin vs. Lucentis vs. others
Avastin: What evidence is available?
P. Lanzetta, Italy
What about VEGF-trap?
U. Schmidt-Erfurth, Austria
New players in the game
G. Soubrane, France
Panel Discussion
Moderator:
N. Bressler, USA
Panel:
F. Boscia, Italy
U. Chakravarthy, UK
P. Dugel, USA
    
14:00-14:30
14:00-14:07
  
14:07-14:15
 
14:15-14:23
 
14:23-14:35
Debate: Optimal treatment for CNV secondary to AMD
Monthy anti VEGF
S. Bressler, USA
PRN anti VEGF
F. Bandello, Italy
Panel Discussion
Moderator:
S. Bressler, USA
Panel:
U. Chakravarthy, UK
P. Dugel, USA
P. Lanzetta, Italy
A. Loewenstein, Israel
G. Soubrane, France
    
14:00-14:30 Coffee Break
   
Session 10
15:00-16:30
Cataract: Complicated Situations in Cataract Surgery II
Chairpersons:
E. Assia, Israel & W.J. Stark, USA
Capsule:
Premium IOLs: Advantages and concerns
  
15:00-15:30
15:00-15:15
  
15:15-15:25
  
15:25-15:30
Debate: Management of cases with weak zonules
Iris fixation technique
W.J. Stark, USA
Capsular anchor
E. Assia, Israel
Discussion
    
15:30-16:00
15:30-15:40
 
15:40-15:50
 
15:50-16:00
Debate: Premium lens
Accommodative IOLs
J. Alio, Spain
Multifocal IOLs
W.J. Stark, USA
Discussion
  
16:00-16:30
Panel Discussion: The premium IOL patient: Happy or unhappy?
Moderator: E. Assia, Israel
Panel:
J. Alio, Spain
Z. Biro, Hungary
G. Kymionis, Greece
W.J. Stark, USA
    
Saturday, March 5, 2011
  
Hall A  
Session 11
08:30-10:00
Tumors I
   
Chairpersons:
L. Zografos, Switzerland & J. Pe'er, Israel
Capsule: Iris tumors - diagnostic and therapeutic considerations
    
08:30-08:50
08:30-08:38
 
08:38-08:46
 
08:46-08:50
 
Debate: Incisional biopsy of the iris
Pro
L. Desjardins, France
Con
N. Bechrakis, Austria
Discussion
  
08:50-09:10
08:50-08:58
 
08:58-09:06
 
09:06-09:10
Debate: Therapeutic approach to iris melanomas
Primary surgery
T. Kivela, Finland
Primary irradiation
B. Damato, UK
Discussion
  
09:10-09:30
09:10-09:18
 
09:18-09:26
 
09:26-09:30
Debate: Circumscribed vs. Global irradiation of anterior segment in iris melanomas
Circumscribed irradiation
L. Desjardins, France
Global irradiation of anterior segment
L. Zografos, Switzerland
Discussion
 
09:30-10:00 
Controversies in the diagnostic approach and management of iris tumors
Discussion on selected Case Reprots
Presenter:
L. Zografos, Swizterland
Discussant:
J. Pe'er, Israel
Panel:
N. Bechrakis, Austria
B. Damato, UK
L. Desjardins, France
T. Kivela, Finland
    
10:00-10:30 Coffee Break
        
Session 12
10:30-12:00
Socioeconomics
Chairperson: N. Bressler, USA
Capsule:
Ethical concerns
  
10:30-11:00
10:30-10:40
  
10:40-10:50
  
10:50-11:00
Part I
Lecture: Is participation in speakers' bureaus unprofessional conduct for physicians who proivde continuing medical education?
N. Bressler, USA
Lecture: An editor’s viewpoint: Conflict of interest and other quandaries
H.D. Jampel, USA
Discussion
  
11:00-11:30
11:30-11:40
 
11:40-11:50
 
11:50-12:00
Part II
Lecture: Pros and Cons regarding industry interactions with physicians in clinical research
N. Bressler, USA
Lecture: Characteristics and impact of the diffusion of medical technologies
G. Barbash, Israel
Discussion
         
12:00-13:00
(Garden Pavilion)
 
12:10-12:20
 
 
12:20-12:30
 
 
12:30-12:40
 
 
12:40-12:50
 
 
12:50-13:00
Glaucoma: A neurodegenerative disease
Lunch Session
  
Lecture: Glaucoma - a neurodegenerative disease
L. Levin, Canada
 
Lecture: Measuring of glaucoma progression
A. Heijl, Sweden
 
Lecture: Managing IOP - the most important risk factor
L. Rossetti, Italy
 
Lecture: What to do when IOP lowering isn't enough
S. Gandolfi, Italy
 
Lecture: Mechanisms behind therapeutic outcomes
F. Cordeiro, UK
      
       
Session 13
13:00-14:30
Glaucoma III
 
Chairpersons: S. Gandolfi, Italy & L. Rossetti, Italy
Capsule:
Hot glaucoma topics in the pipeline
  
13:00-13:30
13:00-13:10
  
13:10-13:20
  
13:20-13:45
Debate: Medical Management of Glaucoma - Neuroprotection
Neuroprotection is a viable 1st line option for glaucoma management
L. Levin, Canada
Neuroprotection should not be part of glaucoma management
F. Cordeiro, UK
Panel Discussion on NP: To be or not to be taht is the Question
Moderator: L. Rossetti, Italy
Panel:
F. Cordeiro, UK
L. Levin, Canada
        
13:45-14:30
13:45-13:55
  
13:55-14:05
 
 
14:05-14:30
Debate: Structure and Function in Measuring rate of progression in Glaucoma
Imaging is the easiest and most cost effective way for following glaucoma progression
TBA
Performing imaging or photography in manifest glaucoma is a waste of resources - instead monitoring using visual fields should be done more often
L. Rossetti, Italy
Panel Discussion
Moderator: A. Heijl, Sweden
Panel:
H.D. Jampel, USA
S. Kurtz, Israel
L. Rossetti, Italy
    
     
  
14:30-15:00 Coffee Break
       
15:00-16:30
(Hall A)
 
Symposium
SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis
 
Moderator: 
A. Cruess, Canada
 
Lecture: European regulation and the practicing ophthalmologist 
P. Bogaert, Belgium
 
Lecture: The regulatory process in action: A case study
K. Khunti, UK
 
Lecture: Understanding the safety profile of anti-VEGF's
P. Kaiser, USA
   
Debate: Off label prescribing, patient safety and the current environment
Panel & audience
 
Summary
Moderator
        
Session 14
16:30-18:00
Neuro-Ophthalmology I
Chairpersons: N. Miller, USA & M. Burdon, UK
Capsule: Optic neuropathy
      
16:30-17:15
Symposium on the treatment of traumatic optic neuropathy
Steroids should be used
A. Lee, USA
Steroids should not be used
A. Arnold, USA
Surgery should be performed
N. Miller, USA
Observation is best
M. Burdon, UK
  
17:15-18:00
Case Presentations
1) Acute isolated 6th nerve palsy in an elderly vasculopath
A. Arnold, USA
A. Kesler, Israel
 
2) Ocular migraine
A. Arnold, USA
 
3) Acute 3rd nerve palsy
A. Arnold, USA
B. Sanchez Dalmau, Spain
 
4) Acquired nystagmus in a patient with MS
M. Burdon, UK
  
5) A patient with IIH and transverse sinus stenosis
L. Castillo, Spain
A. Lee, USA
 
6) A patient with double vision from GCA
A. Kesler, Israel
S. Muñoz, Spain
   
7) A patient with long-standing optic atrophy
Open panel
 
Hall B  
 
Session 15
08:30-10:00
  
Imaging I
Chairpersons: H. Scholl, USA & G. Staurenghi, Italy
Capsule:
Fundus autofluorescence and beyond
  
08:30-09:15
08:30-08:45
 
08:45-09:00
 
09:00-09:15
Debate: Role of autofluorescence for monitoring progression of geographic atrophy in AMD?
Pro
E. Midena, Italy
Con
U. Chakravarthy, UK
Discussion
 
09:15-10:00
09:15-09:30
 
09:30-09:45
 
09:45-10:00
Lecture Series: Beyond conventional autofluorescence
Near-infrared autofluorescence
C. von Strachwitz, Germany
Confocal blue reflectance and two-wavelengh fundus autofluorescence
P. Charbel Issa, UK
Discussion
 
10:00-10:30 Coffee Break
    
Session 16
10:30-12:00
Imaging II
Chairpersons: G. Staurenghi, Italy & H. Scholl, USA
Capsule:
High-resolution optical coherence tomography
  
10:30-11:15
  
10:30-10:45
 
10:45-11:-00
 
11:00-11:15
Debate: Is SD-OCT necessary and sufficient to guide clinical decisions in neovascular AMD or diabetic macular edema?
Yes
U. Schmidt-Erfurth, Austria
No
J. Mones, Spain
Discussion
 
11:15-12:00
  
11:15-11:30
 
11:30-11:45
 
11:45-12:00
Lecture Series: Combining SD-OCT with other imaging and functional technologies
SD-OCT and confocal reflectance imaging - evidence to support the combination
G. Staurenghi, Italy
Structure function-correlation of the central human retina
H. Scholl, USA
Disucssion
  
12:00-13:00
(Garden Pavilion)
Glaucoma: A neurodegenerative disease
Lunch Session
   
    
Session 17
13:00-14:30
Refractive Surgery
Chairpersons: J. Alio, Spain
Capsule:
Upper limits of corneal refractive surgery in myopia and hyperopia will be debated and discussed
 
13:00-13:45
 
13:00-13:15
 
13:15-13:30
 
13:30-13:45
Debate: Stretching the limits of excimer laser surgery: Lasik in high myopia, high hyperopia
High myopia
G. Kymionis, Greece
High hyperopia
D. de Ortueta, Germany
Discussion
  
13:45-14:30
Panel Discussion: Lens based refractive surgery
Moderator:
J. Alio, Spain
Panel:
D. de Ortueta, Germany
G. Kymionis, Greece
C. Verges, Spain
   
14:30-15:00 Coffee Break
    
15:00-16:30
(Hall A)
Symposium
SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis
         
Session 18
16:30-18:00
Medical Retina II
Chairpersons: F. Bandello, Italy & A. Augustin, Germany
Capsule:
Vein occlusion and diabetic retinopathy
  
16:30-17:15
16:30-16:45
 
16:45-17:00
 
17:00-17:15
Debate: What is the first-line treatment of macular edema in retinal vein occlusion?
Corticosteroids
J. Mones, Spain
Anti-VEGF therapy
S. Bressler, USA
Panel Discussion:
1) How should me classify DME?
2) If we initiate anti-VEGF therapy for DME, should it be conbined with laser initially?
Moderator:
J. Mones, Spain
Panel:
S. Bressler, USA
B. Corcostegui, Spain
A. Pollack, Israel
G. Soubrane, France
     
17:15-18:00
17:15-17:30
 
17:30-17:45
 
17:45-18:00
Debate: What is the first-line treatment of macular edema in diabetic macular edema?
Corticosteroids
A. Augustin, Germany
Anti- VEGF therapy
N. Bressler, USA
Panel Discussion:
Moderator:
J. Cunha-Vaz, Portugal
Panel:
B. Corcostegui, Spain
B. Eldem, Turkey
A. Loewenstein, Israel
U. Schmidt-Erfurth, Austria
G. Soubrane, France
   
Hall C    
 
Session 19
08:30-10:00
 
Cornea I
Chairpersons: J. Alio, Spain & W.J. Stark, USA
Capsule:
Corneal ulcers 
    
08:30-09:00
08:30-08:40
 
08:40-08:50
 
08:50-09:00
Debate: Bacterial Corneal Ulcers
No need to culture
G. Kymionis, Greece
Culture is necessary
R. Barraquer, Spain
Disucssion
 
09:00-09:30
09:00-09:10
 
09:10-09:20
 
09:20-09:30
Debate: First-line treatment in corneal ulcer
4th generation flouroquinolones
TBA
Fortified antibiotics
J.P. Alvarez de Toledo, Spain
Discussion
 
09:30-10:00
Panel Discussion: Acanthameba infection
Moderator: J. Alio, Spain
Panel:
J.P. Alvarez de Toledo, Spain
R. Barraquer, Spain
G. Kymionis, Greece
        
10:00-10:30 Coffee Break
   
Session 20
10:30-12:00
Uveitis
Chairpersons:
S. Lightman, UK & P. Sternberg, USA
Capsule:
JRA, ARN
   
10:30-11:00
10:30-10:40
 
10:40-10:50
 
10:50-11:00
 
Debate: Juvenile idiopathic arthritis
Phaco/IOL
S. Taylor, UK
Lensectomy vitrectomy
M. de Smet, The Netherlands
Discussion
   
11:00-11:30
11:00-11:10
 
11:10-11:20
 
11:20-11:30
Debate: Treatment of ARN?
Update of current medical treatment
S. Lightman, UK
The importance of surgical treatment, including laser
P. Sternberg, USA
Panel Discussion
Moderator:
S. Lightman, UK
Panel:
D. Jabs, USA
M. Kramer, Israel
P. Sternberg, USA
S. Taylor, UK
 
11:30-12:00
11:30-11:40
 
11:40-11:50
 
11:50-12:00
Debate: Mucous membrane pemphigoid: Treatment
Early cyclophosphamide
D. Jabs, USA
Stepped approach
M. Kramer, Israel
Discussion
    
12:00-13:00
(Garden Pavilion)
Glaucoma: A neurodegenerative disease
Lunch Session
     
   
Session 21
13:00-14:30
Pediatrics II: Pediatric Ophthalmology
 
Chairpersons:
K.K. Nischal, UK & P. Nucci, Italy
 
Capsule:
Controversies in pediatric external and anterior segment disease
    
13:00-13:45
 
Panel Discussion: Controversies in pediatric anterior segment surgery
Panel:
D. Bremond-Gignac, France
M. Morales Ballus, Spain
A. Serra Castanera, Spain
  
13:45-14:30
 
Panel Discussion: External disease
Panel:
D. Bremond-Gignac, France
J. Prat-Bartomeu, Spain
A. Serra Castanera, Spain
  
     
14:30-15:00 Coffee Break
    
15:00-16:30
(Hall A)
 
Symposium 
SEEING CLEARLY: BALANCING RISK IN OPHTHALMIC PRESCRIBING
Sponsored by Novartis
         
Session 22
16:30-18:00
Cornea II
Chairpersons: W.J. Stark, USA & J. Alio, Spain
Capsule:
Modern keratoplasty techniques
    
16:30-17:00
16:30-16:40
 
16:40-16:50
 
16:50-17:00
Debate: Femtosecond keratoplasty: Is it worthwhile?
Yes
G. Baikoff, France
No
TBA
Discussion
 
17:00-17:10
Lecture: Fuchs' Dystrophy and cataract: Cataract surgery alone or combined with endothelial replacement?
W.J. Stark, USA
  
17:10-17:35
Panel Discussion: Best method for keratoplasty - DSAEK, DMED, Descement menbrane keratoplasty or deep lameller keratoplasty?
Moderator:
W.J. Stark, USA
Panel:
J. Alio, Spain
J. Alvarez de Toledo, Spain
G. Baikoff, France
J. Barraquer, Spain
R. Barraquer, Spain
     
16:35-18:00
Panel Discussion: Keratoprosthesis (Dohlman, Osteodental, Australian)
Moderator:
J. Alio, Spain
Panel:
J. Alvarez de Toledo, Spain
G. Baikoff, France
J. Barraquer, Spain
R. Barraquer, Spain
     
  
Sunday, March 6, 2011
 
Hall A    
 
Session 23
08:30-10:00
 
Tumors II
Chairpersons: J. Pe'er, Israel & L. Zografos, Switzerland
Capsule: Conjunctival tumors - diagnostic and therapeutic considerations
   
08:30-08:50
08:30-08:38
 
08:38-08:46
 
08:46-08:50
 
Debate: Ocular surface squamous neoplasia (OSSN) - How to treat?
Always excision, with or without additional treatment
N. Bechrakis, Austria
Topical chemotherapy as primary treatment
J. Pe'er, Israel
Discussion
 
08:50-09:10
08:50-08:58
 
08:58-09:06
 
09:06-09:10
 
Debate: Primary acquired melanosis: Definition and approach
PAM is adequate and biopsy is unnecessary
T. Kivela, Finland
PAM is inadequate and biopsy is required
B. Damato, UK
Discussion
 
09:10-09:30
09:10-09:18
 
09:18-09:26
 
09:26-09:30
Debate: Large conjunctival melanoma - How to treat?
Excision & additional treatment
B. Damato, UK
External beam radiation - proton/photon
L. Desjardins, France
Discussion
 
09:30-10:00
Controversies in the diagnostic approach and management of conjunctival tumors
Interesting cases with possible controversial approaches
Presenter:
J. Pe'er, Israel
Discussant:
L. Zografos, Switzerland
Panel:
N. Bechrakis, Austria
B. Damato, UK
L. Desjardins, France
T. Kivela, Finland
   
10:00-10:30 Coffee Break
    
Session 24
10:30-12:30
Neuro-Ophthalmology II
Chairpersons: N. Miller, USA & M. Burdon, UK
Capsule:
Treatment issues
  
10:30-11:15
Point-Counterpoint: Medical Therapy in Neuro-ophthalmologic disorders
1) Should patients with NAION be treated with steroids?
Yes
A. Lee, USA
No
A. Arnold, USA
 
2) Should steroids be the first-line drug for patients with ocular myastenia gravis
Yes
N. Miller, USA
No
M. Burdon, UK
 
3) Should immunomodulary drugs be given to high-risk patients with optic neuritis and white-matter lesions on MR?
Yes
A. Arnold, USA
No
M. Burdon, UK
 
4) Topamax for IIH patients who cannot tolerate Diamox: Help or hype?
Helps
A. Lee, USA
Hype
M. Burdon, UK
 
11:15-12:30
Case Presentations
1) OMSM: When do you radiate?
A. Arnold, USA
 
2) Non-organic visual loss in an adult
A. Kesler, Israel
B. Sanchez-Dalmau, Spain
 
3) Non-organic visual loss in a child
A. Lee, USA
S. Muñoz, Spain
 
4) Steroid-dependent optic neuritis
M. Burdon, UK
L. Castillo, Spain
  
Hall B  
Session 25
08:30-10:00
Surgical Retina I
Moderators: A. Augustin, Germany; W. Mieler, USA & J. Moisseiev, Israel; P. Sternberg, USA
Capsule:
Changing trends in vitreo-retinal surgery
    
08:30-09:15
08:30-08:45
 
08:45-09:00
 
09:00-09:15
Debate: Does silicone oil still have a role in complicated RD with PVR?
Pro: Silicone oil is the key to success in these difficult cases
W. Mieler, USA
Con: Silicone oil is not necessary and gas is as effective as silicone
S. Rizzo, Italy
Discussion
 
09:15-10:00
09:15-09:30
 
09:30-09:45
 
09:45-10:00
Debate: Should we perform pneumatic retinopexy?
Pro: Pneumatic retinopexy is a safe and effective treatment for RD
F. Boscia, Italy
Con: Pneumatic retinopexy is dangerous with high failure rate
J. Nawrocki, Poland
Discussion
 
10:00-10:30 Coffee Break
    
Session 26
10:30-12:30
Surgical Retina II
Moderators: A. Augustin, Germany; F. Boscia, Italy; W. Mieler, USA & J. Moisseiev, Israel
Capsule:
Macular surgery
  
10:30-11:10
10:30-10:45
 
10:45-11:00
 
11:00-11:10
Debate: Prone positioning after vitrectomy for macular hole: Is it really necessary?
Pro: Prone positioning of at least 5 days is critical for hole closure
J. Nawrocki, Poland
Con: Prone positioning is not necessary
P. Sternberg, USA
Discussion
 
11:10-11:50
11:10-11:25
 
11:25-11:40
 
11:40-11:50
Debate: Should we operate an ERM with good VA and what technique should we use?
Pro: ERM peeling should be performed in eyes with good VA
J. Moisseiev, Israel
Con: ERM peeling should be performed with VA worse than 20/50
W. Meiler, USA
Discussion
 
11:50-12:00
Case Presentation with Panel Discussion
(2-3 cases)
Presenter:
J. Moisseiev, Israel
Panel:
A. Augustin, Germany
W. Mieler, USA
J. Nawrocki, Poland
P. Sternberg, USA
  

Home   
Copyright © 2008 Comtecmed.com. All rights reserved.   The website was last updated on 03/31/2011 Created by    WebStudio.co.il